Dewpoint Therapeutics is the leading biotechnology company that leverages condensate biology to deliver transformative therapies for patients suffering from diseases of high unmet need.
Through Condensates.com, Dewpoint Therapeutics is committed to providing the community with foundational education in this rapidly developing field, and tools that help promote and accelerate the bench to bed-side application of basic science discoveries. Dewpoint is currently progressing condensate modulating therapy programs across multiple disease indications, including oncology, neurological disorders, metabolic and cardiovascular diseases. Read about our leading platform for discovering condensate-modifying drugs (c-mods).
For additional information, visit the Investors & Media page.
Interested in joining Dewpoint? Visit our Careers page.
Connect with us on LinkedIn and X.
Sign-up for free for personalized content updates.
We’d love to hear from you! Share your feedback and/or suggest new content.